Medicines Distribution Consent




21 MAY 2009

NEW ZEALAND GAZETTE, No. 72

1675

Product:
SOOV IT for Haemorrhoids

Active Ingredients:
Hydrocortisone 0.5%w/w
Lidocaine 5%w/w

Dosage Form:
Rectal ointment

New Zealand Sponsor:
Douglas Pharmaceuticals Limited

Manufacturer:
Ego Pharmaceuticals Pty Limited, Braeside, Victoria, Australia

Product:
Synflorix

Active Ingredients:
Pneumococcal Polysaccharide type 1 1µg
Pneumococcal Polysaccharide type 14 1µg
Pneumococcal Polysaccharide type 18C 3µg
Pneumococcal Polysaccharide type 19F 3µg
Pneumococcal Polysaccharide type 23F 1µg
Pneumococcal Polysaccharide type 4 3µg
Pneumococcal Polysaccharide type 5 1µg
Pneumococcal Polysaccharide type 6B 1µg
Pneumococcal Polysaccharide type 7F 1µg
Pneumococcal Polysaccharide type 9V 1µg

Dosage Form:
Suspension for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturers:
GlaxoSmithKline Biologicals SA, Parc de la Noire Epine, Wavre, Belgium
GlaxoSmithKline Biologicals SA, Rixensart, Belgium

Dated this 15th day of May 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go4364

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Celebrex

Active Ingredient:
Celecoxib 100mg

Dosage Form:
Capsule

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico

Product:
Celebrex

Active Ingredient:
Celecoxib 200mg

Dosage Form:
Capsule

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico

Product:
Celebrex

Active Ingredient:
Celecoxib 400mg

Dosage Form:
Capsule

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico

Product:
Daonil

Active Ingredient:
Glibenclamide 5mg

Dosage Form:
Tablet

New Zealand Sponsor:
sanofi-aventis new zealand limited

Manufacturers:
Aventis Pharma Limited, Verna Industrial Estate, Verna, Goa, India
Sanofi Winthrop Industrie, Compiegne, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Dated this 15th day of May 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go4365



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 72





✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
15 May 2009
Medicines Act 1981, New medicines, Distribution consent, Healthcare products
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

🏥 Consent to Distribution of Changed Medicines

🏥 Health & Social Welfare
15 May 2009
Medicines Act 1981, Changed medicines, Distribution consent, Healthcare products
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health